Friday, June 27, 2014

Silicon Carbide Market Share 2013 - 2019

According to the report, silicon carbide demand was over USD 1.45 billion in 2012 and is expected to reach USD 3.82 billion by 2019, growing at a CAGR of 15.3% from 2013 to 2019. In terms of volume, silicon carbide consumption is expected to reach 2,377.1 kilo tons in 2019, growing at a CAGR of 14.5% from 2013 to 2019.


Growing demand in the steel manufacturing and steel recycling industries and the dependence of electronics & semiconductors on silicon carbide are factors that are expected to drive SiC demand over the next five years. High level of precision involved in the manufacture of components and low tolerance specifications in their applications are expected to be key challenges for market participants in the coming years.
Black and green SiC were the dominant product segments, and accounted for over 90% of the overall market share in 2012. Black SiC is expected to continue holding its market position in the near future and is expected to grow at a CAGR of 15.4% between 2013 and 2019. Green SiC consumption is expected to reach 656.1 kilo tons by 2019. Coated, refractory and metallurgical SiC along with metallurgical briquettes and SiC micro grit accounted for a smaller part of the market with applications in high-performance applications.

Silicon carbide is primarily used in steel & energy, automotives, aerospace & aviation, military & defense, electronics & semiconductors and medical & healthcare end-user segments. Steel & energy showed the highest demand for silicon carbide in 2012 and accounted for more than 28% of the market. Electronics & semiconductors and automotives were the other major segments for the material and are also expected to show strong demand in the near future. Medical & healthcare is expected to show the most demand for silicon carbide during the forecast period and is expected to grow at a CAGR of 15.6% between 2013 and 2019.

Asia Pacific was the largest market for silicon carbide in 2012 and accounted for more than 50% of the global demand. Steel & energy, electronics & semiconductors and automotives were the major markets driving sales for silicon carbide in Asia Pacific, making it the largest market in terms of volume. Asia Pacific and RoW are expected to be strong future markets for silicon carbide owing to growing industrialization and infrastructure. SiC demand in North America and Europe is expected to reach 249.6 kilo tons and 375.6 kilo tons by 2019 respectively. ESK-SIC Gmbh, The Dow Chemical Company, Grindwell Norton Ltd. AGSCO Corporation, Entegris Inc., Norstel AB and Gaddis Engineered Materials along with others were key market participants in the SiC industry.

Silicon Carbide Market: Product Segment Analysis
Black SiC
Green SiC
Others (Coated SiC, refractory SiC, metallurgical SiC and metallurgical briquettes, SiC micro grit)

Silicon Carbide Market: End-user Analysis
Steel & energy
Automotives
Aerospace & aviation
Military & defense
Electronics & semiconductors
Medical & healthcare
Others (Chemicals, fabrication etc.)

Silicon Carbide Market: Regional Analysis
North America
Europe
Asia Pacific
Rest of the World (RoW)


Browse all Chemical Industry Research Reports @ http://www.transparencymarketresearch.com/chemical-market-reports-2.html

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.


Contact
Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com 

Thursday, June 26, 2014

Companion Diagnostics Market Forecast 2013 - 2019

The global companion diagnostics market was valued at USD 1.8 billion in 2012 and is expected to grow at a CAGR of 18.1% from 2013 to 2019, to reach an estimated value of USD 5.6 billion in 2019.

Browse the full report at http://www.transparencymarketresearch.com/companion-diagnostics-market.html

Companion diagnostics are the tests or assays which assist physicians in making efficient treatment decisions depending on the patient response to the ongoing treatment. These tests are developed either once the drug is commercialized or along with the drug in development. The diagnostic test acts as a companion to the drug under investigation and ensures the commercialization of a safer and efficient targeted therapeutic in a very cost effective manner. The most important factors favoring growth of the global companion diagnostics market include the increasing focus of pharmaceutical manufacturers on cost reduction in drug discovery and development, and the rising demand for targeted therapies. Also, continuous exploration of biomarkers and advances in diagnostic technologies will drive the growth and acceptance of companion diagnostics worldwide.

Factors such as lack of compact regulatory guidelines for the development and commercialization of companion diagnostics, high cost of procedures, lengthy developmental and approval phases, and lack of proper reach and availability (particularly in the low income countries) are expected to hamper the ready acceptance of companion diagnostics. Currently, many in vitro diagnostics companies are focusing on the development of accurate and reliable companion diagnostics for various biomarkers. Pharmaceutical companies are either focusing on in-house development of companion diagnostics or development in collaboration with diagnostics companies. This strategy focusing on the co-development of a drug and its companion diagnostic will prove to be advantageous over the conventional development process occurring in isolation.

The global companion diagnostics market can be categorized by tests for various indications and geography. Companion diagnostics market for breast cancer was the most prominent segment of the market in 2012 by revenue. Extensive research on breast cancer biomarkers and a paradigm shift towards personalized medicine will continue to propel the adoption of breast cancer companion diagnostics. However, another attractive segment of this market is that of lung cancer companion diagnostics, with the discovery of lung cancer specific biomarkers and an elaborate pipeline of related companion diagnostics for the same. It is estimated that the global market for lung cancer companion diagnostics will grow at a CAGR of over 20% from 2013 to 2019.

At a regional level, North America was the largest market in 2012 for companion diagnostics, followed by the European region. The favorable healthcare policies, large consumer base, high disposable incomes, increased awareness, presence of suitable infrastructure facilities and ready acceptance of novel approaches in medicine will propel rapid development of companion diagnostics in the North American market. The Asia-Pacific and RoW regions are expected to experience commendable growth by 2019 due to the huge untapped potential, rising disposable incomes and continuous improvements in healthcare infrastructure.

Companion Diagnostics Market, by Indications
  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Melanoma
  • Others (HIV, Thalassemia)
Companion Diagnostics Market, by Geography
·         North America
·         Europe
·         Asia-Pacific
·         Rest of the World (RoW)

Browse all Medical Devices Market Research Reports@ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.


Contact

Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Wednesday, June 25, 2014

Circulating Tumor Cells And Cancer Stem Cells Market Size 2013 - 2019

Globally, CTCs and CSCs Market is estimated to reach USD 7.9 billion by 2018. The study shows that in the overall CTCs and CSCs global market, the U.S. is expected to maintain its lead position in terms of revenue till 2018. The global market for cancer diagnostics based on Circulating Cancer Cells (CTCs) was estimated at USD 1.0 billion in 2011.


The rising prevalence of diseases like cancer and the reimbursement support by regulatory bodies in developed countries like United States and Europe are the major factors driving the growth of the CTCs and CSCs market. Though the currently used detection method lacks sensitivity or specificity to track all CTCs particularly the ones that have lost characteristic epithelial features, there is still good scope for pharmaceutical companies in the CTCs and CSCs field. The various sub-types of cancer may have their own classes and it creates an opportunity in the future.

Increase in cancer mortality rate in the past few years and an increase in number of cancer patients offers an opportunity for pharmaceutical companies to enter this sector. Every one person out of eight has the potential of getting affected by cancer and it is estimated that 12 to 37 lives can be saved daily with the help of CTCs and CSCs.

The major geographic markets for CTCs and CSCs are the U.S. and Europe. The U.S. accounted for more than 50% of the worldwide CTCs and CSC market in 2011.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

SNP Genotyping and Analysis Market Trends 2013 - 2019

The global SNP genotyping and analysis market was valued at USD 2,385.2 million in 2012 and is expected to grow at a CAGR of 21.8% from 2013 to 2019, to reach an estimated value of USD 9,485.2 million by 2019.


SNPs are the most commonly occurring genetic mutations that can be observed in a genome. These are responsible for a person's traits that include strengths and weaknesses. These variations also lead to changes in crop yield, meat and dairy yield among several other factors. The report evaluates the SNP genotyping market which is an aggregate of three facets, instrumentation, reagents or consumables, and services. After the Human Genome Project was concluded a need for faster and cheaper sequencing methods were realized that led to revolutionary changes and eventually ended in vertical drop in sequencing costs. Increasing global gene banks and databases have initiated a series of research and development projects to understand potential of developing diagnostic tests through rapid genotyping techniques.

The market can be perceived to be divided into instruments, reagents or consumables and software and services. Since several technologies in the market are still in the nascent phase, the instruments segment accounts for the largest share as of today but this is expected to change as larger quantities of consumables are used in coming years. The market growth for older systems rises mainly from reagents and consumables as there is low involvement of specialized instrumentation or technologies. The market is expected to decrease further as efforts are initiated to introduce new technologies in these regions and phase out the slower and less efficient methods that are time consuming.

North America accounted for the largest market share in 2012 amongst other regions that included Europe, Asia-Pacific and Rest of the World. Europe's unstable economy has continued to torment the genomics market which SNP genotyping is a part of. Increasing demand from services, animal breeding and livestock, decreasing cost of products and services should encourage the growth of the market in coming years. Asia-Pacific and several countries in RoW region are expected to hold the largest potential in forecast period in terms of revenue. The competitive landscape is oligopolistic. There are leaders in individual market segments, yet in terms of overall popularity; Life Technologies Corporation, Illumina Inc., Affymetrix Inc, Fluidigm, Sequenom and Roche are established to be the key vendors operating in this market
.
SNP Genotyping and Analysis Market, by Technology
·         SNP GeneChips and Microarrays
·         Taqman Allelic Discrimination
·         SNP by Pyrosequencing
·         AB SNPlex
·         MassARRAY MALDI-TOF
·         Others

SNP Genotyping and Analysis Market, by Application
·         Pharmaceuticals and Pharmacogenomics
·         Diagnostic Research
·         Agricultural Biotechnology
·         Breeding and Animal Livestock

SNP Genotyping and Analysis Market, by Geography
·         North America
·         Europe
·         Asia-Pacific
·         Rest of the World (RoW)

Browse all Pharmaceutical Market Research Reports @ http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

Ophthalmology Diagnostics and Surgical Devices Market Share 2013 - 2019

The global Ophthalmology Devices market was valued at USD26,012.6million in 2012 and estimated to reach a market worth USD40,381.6 million in 2019 at a CAGR of 6.6 % from 2013 to 2019.

Browse Global Ophthalmology Diagnostics and Surgical Devices Market Report with Full TOC at http://www.transparencymarketresearch.com/ophthalmology-diagnostics-surgical-devices.html

Ophthalmology, a branch of medicine deals with the detailed study of anatomy, physiology and several ocular disorders. Maintenance of normal vision of eyes is of prime importance as they are vulnerable to trauma, inflammation or infection and constitute asone of the crucial sensory organs. The obsolete nature of medical devices ensures apersistent scope for growth and development of this devices.Ophthalmology industry is witnessing rapid technological advancements that promises immense growth potential in the near future. Rising incidence of several ocular disorders, constant rise in geriatric population and growing demand for enhanced diagnostic and surgical technologies is driving the growth of this market.

Ophthalmology devices market has been analyzed by product type, applications and geography.The product type segment is further classified into three major sub-segments namely diagnostic devices, surgery devices and vision care products.The ophthalmology diagnostic devices market is further segmented into fourteen major diagnostic devices. Technological advances in this field render the diagnostic platforms with high reliability and accuracy to ensure efficient diagnosis. An optical coherence tomography system represented the largest market in the year 2012 and was valued at USD 352.1 million. Few examples of technological advances in diagnostic platforms are advanced optical coherence systems (iVue compact spectral domain OCT unit) and implantable miniature telescopes. These devices provide high resolution imaging and improved visual acuity. Moreover, they help in improving the quality of life of the patients.

The needs for effective treatment methods create a huge growth potential for development and commercialization of several surgical devices worldwide. Ophthalmology surgery devices market has been classified majorly into four major segments namely cataract, refractive, glaucoma and Vitreoretinal surgery devices market. The ophthalmic surgery devices market is expected to exhibit significant growth potential majorly owing to continuous evolution of minimally invasive surgical techniques followed by less intraoperative time consumption and minimal hospital stay. In addition, there has been a consistent rise in patient population being diagnosed for several ocular disorders such as cataract and glaucoma. Accordingto a research report published by the Association of Optometrists sponsored by Bausch & Lomb, it has been projected that approximately 50 million people may become blind due to cataract by 2020. This rise in cataract population is anticipated to fuel the overall growth of the ophthalmology market.

With the advent of new and improved vision care products such as contact lenses and spectacles, has also aided in the proliferation of ophthalmology devices market. The major factors responsible for this growth have been referred to the increasing incidences of refractive disorders (myopia, hyperopia, etc.) and technological advances. The other factors favoring the growth of the market is extensive use of high end technologies involving use of software and computer aided devices and platforms. In addition, changing lifestyle and growing awareness of ophthalmological disorders have also reported to be some of the major contributors for the growth of this industry. Drug eluting contact lenses andvitamin E infused contact lenses are some of the examples of technologically advanced contact lenses.

At the regional level, North America was the largest market in the year 2012 valued at USD 8,037.9 million for ophthalmology devices market followed by Europe market (29.4%).According to the data enlisted by the U.S. Centers of Disease Control and Prevention (CDC) in the year 2013, there are around 20.5 million Americans aged above 40 years are affected by cataract and around USD 3.4 billion is spent by federal governments to treat cataracts through Medicare.This elucidates the increased need and demand of ophthalmology devices market in this region. Asia-Pacific region is expected to grow at a highest CAGR of 8.9 % throughout the forecast period from 2013 to 2019.This is majorly due to increased efforts of respective nation's governments to improve healthcare infrastructure and growing disposable incomes of middle class population.Moreover, increased investments by key market players in the emerging economies and high growth potential will further favor the growth in this region.

Ophthalmology devices market has been characterized by the presence of well-established as well as new entrants solely operating in this market. The major companies competing in this market are Alcon Laboratories (Novartis Company), Topcon Corporation, Bausch & Lomb and Carl Zeiss Meditec AG, Nidek Corporation, Hoya Corporation and others
  • Ophthalmology Diagnostics and Surgical DevicesMarket, by Product Type  
Diagnostic Devices
  • Ophthalmology Diagnostics and Surgical Devices Market, by Applications 
Diagnostics
Surgical
Vision Care
  • Ophthalmology Diagnostics and Surgical Devices Market, by Geography 
North America
Europe
Asia-Pacific
Rest of the World (RoW)

Browse all Medical Devices Market Research Reports @ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

About Us 

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.


Contact

Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Tuesday, June 24, 2014

Contraceptives Market Growth 2012 - 2018

The global contraceptives market was valued at USD 16.0 billion in 2011 and is expected to grow at a CAGR of 5.5% from 2012 to 2018, to reach an estimated value of USD 23.3 billion in 2018.


The growing prevalence of unwanted pregnancies across the globe especially in developed countries such as the U.S. will serve the market as a high impact rendering driver. This is principally due to the fact that governments of countries experiencing a rise in the prevalence of unwanted pregnancies are rigorously promoting the use of contraceptives to curb unnecessary healthcare expenditures associated with abortions. Some of the other drivers of the market include implementation of the Affordable Care Act in the U.S. which has accelerated the growth of the contraceptives market by widening the reimbursement options, rising number of initiatives undertaken by WHO, governments and other NGOs to elevate contraceptive related user awareness and rising global prevalence of sexually transmitted infections. The presence of a strong contraceptives product pipeline and the presence of large unmet contraceptive needs in emerging Asian and African economies will serve the global contraceptives market with future growth opportunities.

In the global contraceptives market by product types (drugs and devices), the contraceptive devices market held majority of the market share in 2011. Moreover, it is expected to exhibit the fastest growth rate during the forecast period owing to its high usage rates and the introduction of new and technologically advanced products such as Bayer's Skyla/Jaydess (a hormonal IUD) in 2012 in Europe and in 2013 in the U.S. The male contraceptive devices (male condoms) market held majority of the market share in 2011 at over 45% owing to its high usage rates induced by its easy-to-use features, cheap prices and high effectiveness. The subdermal contraceptive implants is one of the fastest growing segments in the global contraceptive devices market due to the rising popularity of cheap implants such as Sino-implant (II) and the price reduction of Bayer's Jadelle.

Oral contraceptive pills are the most popular form of temporary birth control and it held majority of the market share in 2011. The global topical contraceptives market is the second fastest growing market after contraceptive pills. Its growth rate is justified by the possible introduction of new products such as AG200-15 by Agile Therapeutics in 2014.

The North American contraceptives market held majority of the market share in 2011 on account of high contraceptive drug usage rate in the region. In addition, the Asian contraceptives market is the fastest growing one due to presence of high unmet contraceptive needs in this region coupled with the rapidly developing economies of India and China.

Some of the key players in the market include Bayer, Church & Dwight Company, Warner Chilcott Company, Agile Therapeutics, BioSante Pharmaceuticals, Mayer Laboratories and others.

Contraceptives Market by Products  
 Contraceptive Drugs
 Oral Contraceptive Pills
 Contraceptive Injectables

Topical Contraceptives
Contraceptive Devices
Male Contraceptive Devices (Male Condoms)
Female Contraceptive Devices
Female Condoms

Diaphragms
Sponges
IUDs
Hormonal IUDs
Copper IUDs
Subdermal Contraceptive Implants
Vaginal Rings

Contraceptives Market by Geography
North America
Europe
Asia-Pacific
Rest of the World (RoW)

Browse all Medical Devices Market Research Reports@ http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.


Contact

Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Photonic Integrated Circuit Market Size 2013 - 2019

Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the market was valued at USD 160.1 million in 2012, which is expected to reach USD 996.2 million by 2019, growing at a CAGR of 31.3% from 2013 to 2019.

Browse Photonic IC Market Report with full TOC at http://www.transparencymarketresearch.com/photonic-integrated-circuit.html

Cost reduction achieved by integrating different optical components such as lasers, detectors, modulators and others into a single unique package is the major driving force for the growth of photonic integrated circuits (PIC) market. Growing application areas, especially in the field of optical communication, sensing and biophotonics coupled with improvements offered in power consumption, reliability and data transfer speed have further fueled the growth of this market. The advancements in computation power and image processing capabilities are expected to have positive impact on the growth of PIC based products in biophotonics applications. The use of photons for the purpose of computation, offering high-speed data processing and data transfer and data provides a sound opportunity for the growth of PIC market.

In 2012, hybrid integration was the major integration technology used in PICs, accounting for 56.3% of the global PIC market. Although hybrid integration is expected to remain the dominant integration technology, monolithic integration is expected to grow at the fastest CAGR of 36.3% from 2013 to 2019. This can be attributed to the improvements offered in reliability, space reduction, power efficiency, and stabilization processes. On the other hand, the share for module integration is expected to decrease over the forecast period owing to its inferior integration capabilities as compared to other integration technologies.

Indium Phosphide and Silicon-on-Insulator are preferred raw materials used in PICs, collectively accounted for two-third of the total revenue generated in 2012. Indium Phosphide has the ability to integrate both optical and passive functions and components. In addition, InP allows cost-effective mass production using advanced high-yield semiconductor manufacturing processes. Silicon substrates, offering ease in fabrication, and relatively low manufacturing cost are also widely used in PICs.

In terms of applications, optical communications held the highest market share, and was valued at USD 100.9 million in 2012.  It is expect to maintain its dominance over the forecast period, growing at a CAGR of 32.9%. This is attributed to growing demand for high-speed communication and rise in data center and WAN applications. In 2012, sensing and biophotonics were the other major application segments, collectively accounting for around 33% of the global PIC market. Optical signal processing application is expected to increase significantly after the commercialization of photonic computing.

North America was the market leader in 2012, followed by Europe and Asia Pacific. Asia Pacific is expected to grow at a CAGR of 35.2% from 2013 to 2019. Increasing number of manufacturing facilities coupled with significant growth in data center applications is expected to fuel the growth in Asia Pacific. The global PIC market is highly fragmented and competitive. Major industry participants include Infinera Corporation (U.S.), Huawei Technologies Co. Ltd (China), Alcatel-Lucent (France), Avago Technologies (Singapore), JDS Uniphase Corporation (U.S.), Finisar Corporation (U.S.), and Intel Corporation (U.S.) among others.

Photonic IC Market, by Integration type
Monolithic integration
Hybrid integration
Module integration
Photonic IC Market, by Raw materials
Indium Phosphide
Gallium Arsenide
Lithium Niobate
Silicon
Silicon-on-Insulator
Others (Silica-On-Silicon, Silicon Dioxide (SiO2), Silicon Nitride (Si3Ni4))

Photonic IC Market, by Components
Lasers
Modulators
Detectors
Attenuators
Multiplexers/De-Multiplexers
Optical Amplifiers
Photonic IC Market, by Application
Optical Communication
Fttx and Access networks
Microwave/RF photonics
Long-haul and Transport networks
Optical datacom
Sensing
Structural engineering
Chemical sensors
Transport and aerospace
Energy and utilities
Optical signal processing
Optical metrology
Optical instrumentation
Quantum optics
Quantum computing
Biophotonics
Medical instrumentation
Photonic Lab-On-A-Chip
Analytics and diagnostics
Optical biosensors

Photonic IC Market, by Geography:
North America
Europe
Asia Pacific
Rest of the World (Latin America, Middle East and Africa)

Browse Semiconductor & Electronics Market Research Reports @ http://www.transparencymarketresearch.com/semiconductor-market-reports-5.html

About Us

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.


Contact
Ms. Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com